Pai Jennifer K, Pischon Tobias, Ma Jing, Manson JoAnn E, Hankinson Susan E, Joshipura Kaumudi, Curhan Gary C, Rifai Nader, Cannuscio Carolyn C, Stampfer Meir J, Rimm Eric B
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.
N Engl J Med. 2004 Dec 16;351(25):2599-610. doi: 10.1056/NEJMoa040967.
Few studies have simultaneously investigated the role of soluble tumor necrosis factor alpha (TNF-alpha) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial.
We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in the Nurses' Health Study and men participating in the Health Professionals Follow-up Study in nested case-control analyses. Among participants who provided a blood sample and who were free of cardiovascular disease at baseline, 239 women and 265 men had a nonfatal myocardial infarction or fatal coronary heart disease during eight years and six years of follow-up, respectively. Using risk-set sampling, we selected controls in a 2:1 ratio with matching for age, smoking status, and date of blood sampling.
After adjustment for matching factors, high levels of interleukin-6 and C-reactive protein were significantly related to an increased risk of coronary heart disease in both sexes, whereas high levels of soluble TNF-alpha receptors were significant only among women. Further adjustment for lipid and nonlipid factors attenuated all associations; only C-reactive protein levels remained significant. The relative risk among all participants was 1.79 for those with C-reactive protein levels of at least 3.0 mg per liter, as compared with those with levels of less than 1.0 mg per liter (95 percent confidence interval, 1.27 to 2.51; P for trend <0.001). Additional adjustment for the presence or absence of diabetes and hypertension moderately attenuated the relative risk to 1.68 (95 percent confidence interval, 1.18 to 2.38; P for trend = 0.008).
Elevated levels of inflammatory markers, particularly C-reactive protein, indicate an increased risk of coronary heart disease. Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.
很少有研究同时调查可溶性肿瘤坏死因子α(TNF-α)受体1型和2型(sTNF-R1和sTNF-R2)、C反应蛋白及白细胞介素-6作为心血管事件预测指标的作用。这些炎症标志物作为独立预测指标的价值仍存在争议。
在巢式病例对照分析中,我们检测了参与护士健康研究的女性和参与卫生专业人员随访研究的男性血浆中sTNF-R1、sTNF-R2、白细胞介素-6及C反应蛋白水平,将其作为冠心病风险标志物。在基线时提供血样且无心血管疾病的参与者中,分别有239名女性和265名男性在8年和6年随访期间发生非致死性心肌梗死或致死性冠心病。采用风险集抽样方法,我们按2:1的比例选取对照,并匹配年龄、吸烟状况和血样采集日期。
在对匹配因素进行校正后,白细胞介素-6和C反应蛋白水平升高与两性冠心病风险增加均显著相关,而可溶性TNF-α受体水平升高仅在女性中具有显著意义。进一步对脂质和非脂质因素进行校正后,所有关联均减弱;只有C反应蛋白水平仍具有显著意义。与C反应蛋白水平低于1.0mg/L的参与者相比,C反应蛋白水平至少为3.0mg/L的所有参与者的相对风险为1.79(95%置信区间为1.27至2.51;趋势P<0.001)。对是否患有糖尿病和高血压进行额外校正后,相对风险适度降至1.68(95%置信区间为1.18至2.38;趋势P = 0.008)。
炎症标志物水平升高,尤其是C反应蛋白,表明冠心病风险增加。尽管血浆脂质水平与风险增加的关联比炎症标志物更强,但C反应蛋白水平仍是冠心病预测的重要因素。